George Scangos
2018
In 2018, George Scangos earned a total compensation of $783K as President and Chief Executive Officer at Vir Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $260,000 |
|---|---|
| Salary | $512,019 |
| Other | $11,000 |
| Total | $783,019 |
Scangos received $512K in salary, accounting for 65% of the total pay in 2018.
Scangos also received $260K in non-equity incentive plan and $11K in other compensation.
Rankings
In 2018, George Scangos' compensation ranked 10,283rd out of 14,244 executives tracked by ExecPay. In other words, Scangos earned more than 27.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,283 out of 14,244 | 28th |
Division Manufacturing | 4,144 out of 5,765 | 28th |
Major group Chemicals And Allied Products | 1,558 out of 2,128 | 27th |
Industry group Drugs | 1,314 out of 1,817 | 28th |
Industry Biological Products, Except Diagnostic Substances | 253 out of 339 | 25th |
Source: SEC filing on April 6, 2020.
Scangos' colleagues
We found one more compensation record of an executive who worked with George Scangos at Vir Biotechnology in 2018.
2018
Herbert Virgin
Vir Biotechnology